Sanchez, G. A. M. Et Al. 2017. Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases. ARTHRITIS & RHEUMATOLOGY , vol.69 .

Sanchez, G. A. M., Reinhardt, A., Ramsey, S., Wittkowski, H., Hashkes, P. J., Murias, S., ... Berkun, Y.(2017). Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases. ARTHRITIS & RHEUMATOLOGY , vol.69.

Sanchez, Gina Et Al. "Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases," ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Sanchez, Gina A. Et Al. "Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases." ARTHRITIS & RHEUMATOLOGY , vol.69, 2017

Sanchez, G. A. M. Et Al. (2017) . "Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases." ARTHRITIS & RHEUMATOLOGY , vol.69.

@article{article, author={Gina A. Montealegre Sanchez Et Al. }, title={Response to JAK1/2 Inhibition with Baricitinib in "Candle", "Savi" and "Candlelike" Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2017}